from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2468c/-

LFCtreatmentdescriptionclass of inhibitor

-0.217

Amikacinug/mL Amikacintranslation

0.151

Cap5-10ug/mL Capreomycintranslation

-0.078

Rox10-50 ug/mL Roxithromycintranslation

0.441

SM2-5 ug/mL Streptomycintranslation

0.527

Tet5-10 ug/mL Tetracyclinetranslation

0.091

Rif0.2-5ug/mL Rifampicintranscription

-0.332

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.026

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.791

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-1.161

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.960

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.011

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.649

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.196

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.581

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.495

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.272

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.510

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.126

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.507

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.219

KCN5-20 ug/mL Potassium cyaniderespiration

0.207

NaN30.2-2 mM Sodium aziderespiration

0.418

Nigericin50 uM Nigericinrespiration

-1.290

TRC10-150 ug/mL Triclosanrespiration

-2.298

TRZ10-25 ug/mL Thioridazinerespiration

-1.256

Valinomycin0.5-10 uM Valinomycinrespiration

0.156

ZnSO42 mM ZnSO4respiration

0.285

menadione6-10 ug/mL Menadionerespiration

-0.134

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.364

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.105

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.668

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.177

NRP_1Non-replicating persistence stage 1dosRassociated

0.440

Amp0.2mg/mL AmpicillincellWall

0.569

Cephalexin20-100 ug/mL CephalexincellWall

0.646

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.102

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.542

EMB10-20 ug/mL EthambutolcellWall

0.931

Eta12-40 ug/mL EthionamidecellWall

0.884

INH0.2-0.4 ug/mL IsoniazidcellWall

0.505

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.365

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.262

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.675

BZA0.12 mg/mL BenzamidearomaticAmides

-0.158

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.875

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.215

H2O24 mM hydrogen peroxideDNAdamaging

0.131

Levo10 ug/mL LevofloxacinDNAdamaging

0.816

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.107

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.597

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.697

UVUV-irradiationDNAdamaging

-1.036

ARP41-4 ug/mL Antitubercular compound ARP4?

0.306

Antimycin12.5-50 ug/mL Antimycin A?

0.377

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.293

PA_110-50 ug/mL Antitubercular compound PA-1?

0.143

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.114

PA8240.2-2 ug/mL PA-824?

-0.202

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.751

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.221

Verapamil50 uM Verapamil?

0.712

mercaptoethanol2 mM 2-Mercaptoethanol?

0.481

methoxatin10-20 ug/mL Methoxatin?